Showing results (311-320 of 463) with videos related to

Sort By:
Pageof 47
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2019
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?Yvette C Wong, Kelvin Luk, Kerry Purtell, et al.
Frontiers in Neurology|September 9, 2022
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Frontiers in Neurology|November 22, 2021
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Plos One|March 8, 2013
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet needKallol Ray Chaudhuri, Jose Manuel Rojo, Anthony H V Schapira, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2024
Continuous Levodopa Delivery with an Intraoral Micropump System: An Open-Label Pharmacokinetics and Clinical StudyC Warren Olanow, Deborah McIntyre, Michele Matarazzo, et al.
Frontiers in Neurology|December 31, 2025
Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuationsJoaquim J Ferreira, Fabrizio Stocchi, Angelo Antonini, et al.
Neurology|June 15, 2014
Prevalence of fatigue in Parkinson disease and its clinical correlatesFabrizio Stocchi, Giovanni Abbruzzese, Roberto Ceravolo, et al.
Experimental Neurology|June 24, 2008
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory responseMahmoud M Iravani, Mona Sadeghian, Clement C M Leung, et al.
Frontiers in Cellular Neuroscience|July 29, 2015
NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patientsManuela Mellone, Jennifer Stanic, Ledia F Hernandez, et al.
Proteomics|September 21, 2004
Induction of Mycobacterium avium proteins upon infection of human macrophagesLara Brunori, Federico Giannoni, Luca Bini, et al.
Pageof 47